UK’s first self-administered injectable could open doors

25th September 2015

Sayana Press first self-administered injectable

The UK market for contraceptives has received a new addition, expanding choice not just in the UK but potentially worldwide. A leading UK regulatory authority, the Medicines & Healthcare products Regulatory Agency (MHRA), has authorized self-injection of Pfizer’s subcutaneous injectable contraceptive, Sayana® Press, in that country. This update makes for the first injectable contraceptive in the UK available for self-administration. Sayana Press is packaged in the Uniject™ injection system, developed by PATH, combining one dose of the contraceptive and a single-use needle in one device. Pfizer’s announcement includes plans to seek regulatory approval of the updated Sayana Press label in a number of additional countries with unmet need and demand for injectable contraception, such as Burkina Faso, Uganda, and Senegal. Read more here.


You are currently offline. Some pages or content may fail to load.